News

Engagement of Altimmune at Notable Investor Conferences Ahead

Engagement of Altimmune at Notable Investor Conferences Ahead

Altimmune to Present at Significant Investor Conferences

GAITHERSBURG, Md. — Altimmune, Inc. (Nasdaq: ALT), a pioneering biopharmaceutical company, is dedicated to developing innovative peptide-based therapeutics targeting liver and cardiometabolic disorders. The Company is gearing up for participation in two noteworthy investor conferences, where members of its management team will engage with attendees and conduct one-on-one meetings.

Upcoming Conference Details

Altimmune's presence at these events marks an opportunity for investors to gain insights into the company's advancements and strategic vision. The conferences include:

H.C. Wainwright 3rd Annual BioConnect Investor Conference

Scheduled for May 20, this conference located in New York will feature a fireside chat at 10:00 a.m. Eastern Time, providing a platform for Altimmune to share its progress and future aspirations.

Jefferies Global Healthcare Conference

On June 4, Altimmune will participate in another significant event in New York, with a fireside chat set for 9:55 a.m. Eastern Time. This engagement will further highlight the Company’s commitment to investors and stakeholders in the healthcare community.

Accessing the Presentations

The sessions will be streamed live, allowing interested parties to follow along and engage with the presented content. For those wishing to view the presentations, the webcast can be accessed via the Events section of the Altimmune website, ensuring everyone can stay informed about the latest developments in the company's research and initiatives.

About Altimmune and Its Innovations

Altimmune is at the forefront of developing forward-thinking biopharmaceutical solutions. The Company’s leading program, pemvidutide, is gaining notoriety as a dual GLP-1/glucagon receptor agonist and is instrumental in treating conditions such as metabolic-associated steatotic liver disease (MASH), obesity, Alcohol Use Disorder (AUD), and Alcohol Liver Disease (ALD). These therapeutic innovations highlight Altimmune's pivotal role in combating significant health challenges.

Discover more about the groundbreaking work at Altimmune by visiting their official website or social media channels.

Company Contacts

If you have inquiries regarding company updates or investor relations, feel free to reach out to:

Company Contact:

Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
Email: ir@altimmune.com

Investor Contact:

Lee Roth
Burns McClellan
Phone: 646-382-3403
Email: lroth@burnsmc.com

Media Contact:

Jake Robison
Inizio Evoke Comms
Phone: 619-849-5383
Email: Jake.robison@inizioevoke.com

Frequently Asked Questions

What is the main focus of Altimmune?

Altimmune focuses on developing innovative peptide-based therapeutics aimed at treating liver and cardiometabolic diseases.

When are the upcoming conferences Altimmune will attend?

Altimmune will participate in the H.C. Wainwright BioConnect Conference on May 20, followed by the Jefferies Global Healthcare Conference on June 4.

How can I access Altimmune’s presentations during the conferences?

The presentations will be available via live stream on Altimmune's website under the Events section.

What is pemvidutide?

Pemvidutide is Altimmune’s lead therapeutic program, designed as a dual GLP-1/glucagon receptor agonist that targets conditions like obesity and liver diseases.

How can I get in touch with Altimmune for investor queries?

Investors can contact Greg Weaver, the CFO, at 240-654-1450 or via email at ir@altimmune.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
Celebrating Appalachian Soul with Aristotle Jones

Updated Category News Views 5

Igniting a Celebration of Appalachian Soul Now here's a sound that hits you right in the gut. Aristotle Jones, known out there as the 'Appalachian Soul Man,' is making a big move. He's laying out the plan to make July the Appalachian Soul Month. This fellow isn't shy about celebrating the deep roots of Appalachian music, dropping his album Appalachian Soul Power and a new...

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Community Leaders: The New Handbook for Governance

Updated Category News Views 113

Empowering Community Leaders with Essential Resources Community Associations Institute, a renowned authority in the realm of condominium and homeowners associations, has recently unveiled a transformative resource titled Board Member Handbook: A Guide for Community Association Leaders. This handbook is meticulously crafted to bolster the capabilities of volunteer board...

Continue Reading
Terran Orbital Faces Class Action Amid Falling Stock, Key Insights

Updated Category News Views 73

Understanding the Terran Orbital Class Action Lawsuit Pomerantz LLP has initiated a class action lawsuit against Terran Orbital Corporation (NYSE: LLAP) and its executives. The lawsuit, filed in a Florida district court, aims to represent individuals and entities that acquired Terran's securities within a defined class period, seeking restitution for alleged damages due...

Continue Reading
Johnson & Johnson's Promising Myeloma Treatment Achieves Success

Updated Category News Views 240

Recent Developments in Myeloma Treatment Johnson & Johnson has made significant strides recently, demonstrating strong clinical efficacy with an innovative immune-based treatment for multiple myeloma. The combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase) has showcased remarkable effectiveness in newly diagnosed patients who are...

Continue Reading
OSE Immunotherapeutics Shares Breakthrough Findings on Novel Treatment

Updated Category News Views 217

OSE Immunotherapeutics Unveils New Treatment Insights OSE Immunotherapeutics, a prominent biotech company, has shared exciting preclinical data regarding its innovative treatment targeting chronic colitis. The focus of this groundbreaking research is the combination of the anti-IL-7 receptor, Lusvertikimab, with an anti-IL-12/23 monoclonal antibody. Presented during an...

Continue Reading
Antibiotics Market Poised for Growth to USD 72.9 Billion

Updated Category News Views 147

Antibiotics Market Overview Antibiotics are essential medications that play a critical role in modern medicine, addressing various bacterial infections and contributing significantly to public health. The antibiotics market is currently valued at approximately USD 50.8 billion and is projected to surge to USD 72.9 billion by 2032, representing a compound annual growth...

Continue Reading